Researc of pro- and anti-inflammatory cytokines dynamic on the background of endothelial dysfunction development induced by experimental osteoarthrosis
Keywords
osteoarthritis, experimental model, endothelial dysfunction, Interleukin 1β, Interleukin 10, aminoguanidine, L-arginineAbstract
Study have been carried out on white Wistar line rats (age – 3 months, weight – 180-220 g). According to the tasks the animals were divided into 7 groups:
1st group is intact (n = 20). 2nd group is rats, which were modeled osteoarthritis without further correction and were withdrawn from the experiment in the first stage (7th day) (n=40). 3rd group is rats, which were modeled osteoarthritis without further correction and removed from the experiment in the second stage (21st day) (n=40). 4th group is rats, in which experimental osteoarthritis was corrected with nonsteroidal anti-inflammatory drugs (NSAIDs) (Diclofenac) and aminoguanidine and removed from the experiment in the first stage (7th day) (n=20). 5th group is rats, in which experimental osteoarthritis was corrected with NSAIDs (Diclofenac) and aminoguanidine and withdrawn from the experiment in the second stage (21st day) (n=20). 6th group is rats, where experimental osteoarthritis was corrected using NSAIDs and a 7% L-arginine solution and withdrawn from the experiment in the first stage (7th day) (n=20). 7th group is rats, in which experimental osteoarthritis was corrected with NSAIDs and 7% L-arginine solution and withdrawn from the experiment in the second stage (21st day) (n=20). Animals were withdrawn from the experiment for the 7th day and the 21st day after the simulation of the pathological condition. NSAIDs (Diclofenac), aminoguanidine and L-arginine were administered from the beginning of the study.
It were found during the experiment, increased levels of Interleukin 1β and Interleukin 10 in the simulated osteoarthrosis pathogenesis. It has been established positive dynamics of these cytokines in the endothelial dysfunction correction at osteoarthritis with the aminoguadine correction. It was revealed more pronounced efficacy of using L-arginine as a corrective means of impaired endothelial function in experimental osteoarthritis. Comparative characteristics of correction agents has shown that the use of nitric oxide donor is more effective than incubation of inducible NO synthase. It was proved normalization of endothelial functional status indicators in the group of animals treated with L-arginine as a part of complex correction of osteoarthrosis was proved.
References
Furberg CD, Psaty BM, Fitzgerald CA. Parecoxib, Valecoxib and cardiovascular risk. Circulation. 2005;111:249-252.
Klinicheskie rekomendacii. Revmatologija. Pod red Nasonova EL. M: GJeOTAR-Media. 2008:99-111.
Klinicheskie rekomendacii. Revmatologija. Pod red Nasonova EL. M: GJeOTAR-Media. 2010:327-344.
Mihlina M, Men'shikova I, Sulimov V. Primenenie preparatov gialuronovoj kisloty u pacientov s osteoartrozom kolennogo sustavaju Vrach. 2010;5:61-64.
Nasonov EL. Klinicheskie rekomendacii. Revmatologija. M: GJeOTAR-Media. 2008:288.
Naumov AV, Shamuilova MM. Osteoartroz v sovremennoj klinicheskoj praktike: analiz faktorov i rekomendacii. Terapevt. 2009;10:5-33.
Cvinger SM. Kliniko-patogeneticheskoe znachenie izmenenij nekotoryh pokazatelej vospalenija i sosudisto-trombocitarnogo gemostaza u bol'nyh pervichnym osteoartrozom.14.01.04 - vnutrennie bolezni. Chita. 2011.
Makolkin VI, Pak JuV, Men'shikova IV. Koksartroz - voprosy jetiologii, jepidemiologii, klinicheskih projavlenij i novyh podhodov k lecheniju. Terapevticheskij arhiv. 2007;1:81-85.
Badokin VV. Puti optimizacii terapii osteoartroza. Russkij medicinskij zhurnal. 2006;14(25):1824-1826.
Egorov IV, Curko VV. Sustavnoj sindrom v revmatologii: sovremennaja patogeneticheskaja koncepcija i obosnovanie terapevticheskogo primenenija nimesulida. Farmateka. 2008;8:37- 41.
Kotel'nikov TP, Larcev JuV. Osteoartroz: rukovodstvo. M: GJeOTAR – Media. 2009:208.
Badokin VV. Piaskledin - hondroprotektivnyj preparat s anticitokinovoj aktivnost'ju. Consilium medicum. 2007;9(8):147-152.
Popov AA, Izmozherova NV, Tachiceva NV. Rasprostranennost' osteoartroza kolennogo sustava i ego vlijanie na kachestvo zhizni zhenshhin v klimakterii. Nauchno-prakticheskaja revmatologija. 2007;2:8-13.
Curko VV, Egorov IV, Krasnosel'skij MJa. Sustavnoj sindrom u pozhilyh: patofiziologija boli i kliniko-vozrastnye aspekty terapii. Consilium medicum. 2009;2(11):44-49.
Medvedeva NA, D'jakonov KB, Postnikov AB, Bonarcev AP, Slavuckaja AV. Snizhenie oksid azota (NO)-cGMF-zavisimoj rasshiritel'noj reakcii sosudov malogo kruga krovoobrashhenija pri disfunkcii jendotelija. Rossijskij fiziologicheskij zhurnal. 2005;2:132-140.
Vvedenskij BP, Tynynyka LN, Kovalev GA, Sandomirskij BP. Soderzhanie konechnogo produkta oksida azota v hrjashhe i syvorotke krovi krys pri nizkotemperaturnom modelirovanii destruktivno- distroficheskogo processa v kolennom sustave. Problemy kriobiologi. 2011;21(4):421-428.
Ketlinskij SA, Simbircev AS. Citokiny. OOO «Izdatel'stvo Foliant», SPb. 2008:552.
Korolev A, Curko B. Rol' citokinov v razvitii osteoartroza. Vrach. 2003;6:58-60.
Fernandes JC, Martel-Pelletier J, Pelletier JP. The role of cytokines in osteoarthritis pathophysiology. Biorheology. 2002;39(1-2):237-246.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 139
Number of citations: 0